ThirdWaveRx的动态

I took on two different independent pharmacies as clients recently, both needing help to implement a 340B contract pharmacy relationship with a local covered identity. This relationship is not without risk for the contract pharmacy— The terms of the arrangement are important to get right. Properly implemented, these are synergistic relationships where an independent pharmacy is a true partner in caring for mutual patients. #340B #pharmacy #healthcare #340Bprogram #pharmacy #pharmacists https://lnkd.in/gQnR6imG

For a nuanced and detailed look into potential PBM reform, we suggest reading this report. It reinforces the important work PBMs perform in negotiating drug costs for payers and patients, a role we understand firsthand as partners of several specialty PBMs. #Pharmacy #Healthtech #Healthcare https://lnkd.in/g5u5hGPg

The FTC just released an interim report on how PBMs drive?up costs?for medicines?and drive?out independent pharmacies.?This report builds on additional efforts from Congress and federal and state agencies – including FTC, DOJ, HHS and state attorneys general – looking at?harmful PBM practices.? ? The three largest PBMs?controlled?80% of the?prescriptions dispensed in 2023 and are vertically integrated with?large insurers, providers, and pharmacies. As the WSJ reports, we are seeing how PBMs anti-competitive practices are now pushing patients to use PBM-owned specialty pharmacies to fill prescriptions. These middlemen are?using opaque practices to control?where you get your medicine and what you will pay at the pharmacy, all while pushing out independent pharmacies and marking up costs for patients.? ?https://lnkd.in/eCFYKYis

National CooperativeRx has developed a three-part blog series where we explore pharmacy benefit management concepts at a high level and address frequently asked questions. In the second part of our series, we delve into the inner workings of PBMs, answering questions about what happens after a patient fills a prescription, how benefits are managed effectively, and the strategic approaches PBMs utilize. #NationalCooperativeRx #PharmacyBenefits #MemberEducation

A new FTC interim report underscores how pharmacy benefit managers (PBMs) profit at patients’ expense and drive up medicine costs.? ? The report details how PBMs: ?? steer patients to?pharmacies?they own ?? control what medicines are covered and what patients pay?for them ?? reduce competition?and push out independent pharmacies ?? pocket rebates meant for patients??

Now available in the October issue of Radar on Specialty Pharmacy: The latest on PBM private-label units, how flexible CAR-T monitoring could help with post-treatment barriers, employers aren't happy with PBM's specialty pharmacy services, and more top stories. https://hubs.ly/Q02S-Wkf0

It is so very wrong, many say criminal, that we allow people who are in need of important, so often life sustaining medicines like insulin that we allow PBMs to “set/control” the price of these drugs here in the US at 6 to 10 times more than all of western Europe, Scandinavia, Canada, Australia, New Zealand, Japan, etc. It is important to understand that 20% to 25% of the 9M+ people that use insulin in our United States cannot afford these inflated prices and have to ration their insulin which sadly brings on ill health when they do not take the proper insulin dose allowing the development of far more serious, disabling, and costly complications of diabetes. These excessive profits made only here in the U.S. are not justified. Insurance companies and insulin manufacturers throughout the world make a profit in all of these countries listed above. PBMS do not exist anywhere else in the world other than the United States. In our awesome country, we allow these 3 groups led by the PBMS to have a rebate system that gives them even more profits when they set the price of these medicines at criminally high levels. There is no other business in the United States that is allowed to work with partners to set the price (is this price fixing?) and then receive the cash rebates. All other businesses that offer rebates have the rebates go back to the consumers. Our political leaders who care and honestly serve us and not these big companies must demand full transparency of all costs and revenues and ensure that the price of medicines are not hyperinflated.

Providers who work with AIS Healthcare know that we are more than just a compounding pharmacy. We are a partner in managing chronic pain and spasticity, and we work tirelessly to ensure the highest levels of safety and sterility in all our medications. Listen to members of our medical advisory board as they explain what separates AIS Healthcare from other compounding pharmacies. #AISCAREGROUP #pharma #tdd #painmanagement #healthcare

Pharmacies have been seeing a decrease in growth and many have even been closing. One of the reasons that pharmacies have been closing is due to Pharmacy Benefit Managers (PBMs). PBMs are intermediaries between insurers and pharmacies that negotiate drug prices and reimbursement rates. Often times, PBMs negotiate rates that are not suitable for smaller pharmacies, squeezing their profit margins. Additionally, PBMs sometimes require patients to use specific pharmacies, often their own or those with which they have contracts, further reducing business for independent pharmacies. #Pharmacy #PharmLife #PharmacyTech #Pharmacist #PharmacyTechnician

NCPDP publishes new guidance on standards for professional service billing for pharmacists. Important step in recognizing the shift from dispensing to payment for value based services in community pharmacy. Value Drug Company https://lnkd.in/e67HSGve